OverviewChartNewsTraderScreen

LBBW Aktienanleihe MRK 24.05.2024/  DE000LB38HD9  /

Stuttgart
5/15/2024  9:46:23 AM Chg.-0.010 Bid10:00:44 PM Ask10:00:44 PM Underlying Strike price Expiration date Option type
99.730EUR -0.01% -
Bid Size: -		 -
Ask Size: -		 MERCK KGAA O.N. 125.93 - 5/24/2024 Call
GlobeNewswire 12:00 AM Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/15 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 5/15 Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VIS...
GlobeNewswire 5/15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 5/15 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/15 PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
TeleTrader 5/15 Europe opens higher with data in limelight
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 5/6 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 5/2 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 4/2 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/4 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 2/2 Merck Group to expand investment in South Korea
TeleTrader 2/1 Merck's Q4 sales up 6% to $14.6B
TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 1/23 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 12/21/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire 12/14/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
TeleTrader 10/26/2023 Merck's Q3 sales up 7% to $16B
TeleTrader 10/20/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs
GlobeNewswire 10/17/2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
GlobeNewswire 9/28/2023 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
TeleTrader 8/29/2023 US gov't reveals drugs subject to Medicare price debate
TeleTrader 8/1/2023 Merck posts Q2 sales of $15B, rising 3%